ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,588Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 198

$635K Total Retail Price of All Prescriptions

Rank: 39 out of 198

523 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 523 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,276 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 456 384 1 2
HYDROCODONE-ACETAMINOPHEN 409 274 S3 2 8
LEVOTHYROXINE SODIUM 303 264 3 1
AMLODIPINE BESYLATE 302 291 4 4
FUROSEMIDE 296 277 5 5
TRAMADOL HCL 273 252 6 15
LISINOPRIL 270 242 7 6
WARFARIN SODIUM 269 250 8 7
OMEPRAZOLE 250 181 9 3
METOPROLOL TARTRATE 242 224 10 10
POTASSIUM CHLORIDE 202 172 11 9
METOPROLOL SUCCINATE 183 178 12 11
GLIMEPIRIDE 173 163 13 35
ATORVASTATIN CALCIUM 172 146 14 12
NEXIUM 154 138 15 40
CITALOPRAM HBR 153 138 16 20
METFORMIN HCL 141 126 17 13
GABAPENTIN 134 130 18 14
PRAVASTATIN SODIUM 132 119 19 19
CRESTOR 121 86 20 26
QUINAPRIL HCL 120 107 21 145
ALLOPURINOL 109 105 22 23
CIPROFLOXACIN HCL 105 97 23 55
DONEPEZIL HCL 102 102 24 28
TRIAMTERENE-HCTZ 99 89 25 32
HYDROCHLOROTHIAZIDE 97 89 26 16
SYNTHROID 90 85 27 36
SERTRALINE HCL 89 85 28 25
BENAZEPRIL HCL 84 71 29 45
ZETIA 83 70 30 68
MELOXICAM 81 61 31 30
PREDNISONE 79 73 32 29
VYTORIN 78 70 33 145
ATENOLOL 77 71 34 17
ALENDRONATE SODIUM 76 76 35 21
DIOVAN 75 70 36 34
PAROXETINE HCL 70 69 37 65
PLAVIX 70 70 37 66
CLOPIDOGREL 68 67 39 42
RAMIPRIL 64 53 40 72
FAMOTIDINE 64 64 40 57
CELEBREX 59 56 42 59
AMITRIPTYLINE HCL 57 42 R 43 69
TRAZODONE HCL 57 33 43 50
PANTOPRAZOLE SODIUM 56 49 45 31
AZITHROMYCIN 56 44 45 56
NAMENDA 55 55 47 33
LOSARTAN POTASSIUM 55 55 47 18
METFORMIN HCL ER 54 45 49 64
FENOFIBRATE 54 54 49 61
DIGOXIN 53 53 51 43
RANITIDINE HCL 52 28 52 54
DEXILANT 52 52 52 188
CYCLOBENZAPRINE HCL 51 31 R 54 67
JANUVIA 51 46 54 86
CLONIDINE HCL 51 51 54 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.